ALK-Abello A/S (AKBLF)
37.92
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
ALK-Abello Debt to Equity Ratio : 0.0608 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0608 |
| March 31, 2026 | 0.0624 |
| December 31, 2025 | 0.0649 |
| September 30, 2025 | 0.0752 |
| June 30, 2025 | 0.1012 |
| March 31, 2025 | 0.1409 |
| December 31, 2024 | 0.2209 |
| September 30, 2024 | 0.1003 |
| June 30, 2024 | 0.1031 |
| March 31, 2024 | 0.1104 |
| December 31, 2023 | 0.172 |
| September 30, 2023 | 0.1654 |
| June 30, 2023 | 0.1745 |
| March 31, 2023 | 0.1552 |
| December 31, 2022 | 0.1745 |
| September 30, 2022 | 0.1654 |
| June 30, 2022 | 0.1704 |
| March 31, 2022 | 0.171 |
| December 31, 2021 | 0.204 |
| September 30, 2021 | 0.2357 |
| June 30, 2021 | 0.2407 |
| March 31, 2021 | 0.2841 |
| December 31, 2020 | 0.2991 |
| September 30, 2020 | 0.2991 |
| June 30, 2020 | 0.2994 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3004 |
| December 31, 2019 | 0.3117 |
| September 30, 2019 | 0.299 |
| June 30, 2019 | 0.3012 |
| March 31, 2019 | 0.2909 |
| December 31, 2018 | 0.2334 |
| September 30, 2018 | 0.2271 |
| June 30, 2018 | 0.2269 |
| March 31, 2018 | 0.2294 |
| December 31, 2017 | 0.2304 |
| September 30, 2017 | 0.2765 |
| June 30, 2017 | 0.2748 |
| March 31, 2017 | 0.2731 |
| December 31, 2016 | 0.2696 |
| September 30, 2016 | 0.2223 |
| June 30, 2016 | 0.2234 |
| March 31, 2016 | 0.2317 |
| December 31, 2015 | 0.2392 |
| September 30, 2015 | 0.2549 |
| June 30, 2015 | 0.2636 |
| March 31, 2015 | 0.1322 |
| December 31, 2014 | 0.1376 |
| September 30, 2014 | 0.1382 |
| June 30, 2014 | 0.1419 |
| March 31, 2014 | 0.1422 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Novo Nordisk A/S | 0.6333 |
| H. Lundbeck A/S | 0.3505 |
| AstraZeneca PLC | 0.7166 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.487B |
| Total Liabilities (Quarterly) | 425.67M |
| Shareholders Equity (Quarterly) | 1.062B |
| Current Ratio | 3.457 |
| Net Debt Paydown Yield | 0.11% |